Immunological products, unmixed, not put up in measured doses or in forms or packings for retail sale
Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products; cell cultures, whether or not modified: > Antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes: > Immunological products, unmixed, not put up in measured doses or in forms or packings for retail sale
Duty Rate (from China)
Articles the product of any country, as provided for in subdivision (aa)(ii) of U.S. note 2 to this subchapter
Products classified under HTS 3002.13.00
Unmixed Monoclonal Antibody Bevacizumab
Bevacizumab is a recombinant humanized monoclonal antibody that inhibits vascular endothelial growth factor (VEGF) for use in cancer therapy. It falls under HTS 3002.13.00 as an unmixed immunological product, not put up in measured doses or retail packings, consistent with chapter note definitions for immunological products like monoclonal antibodies directly involved in immunological regulation. Supplied in bulk liquid form for pharmaceutical compounding.
Bulk Interferon Alpha-2a
Interferon Alpha-2a is a cytokine protein used for antiviral and anticancer treatment, produced via recombinant DNA technology. Classified under HTS 3002.13.00 as an unmixed immunological product per chapter notes, supplied in bulk vials without measured doses or retail packaging for further formulation.
Recombinant Interleukin-2 (IL-2)
IL-2 is a growth factor protein stimulating immune cell proliferation, used in immunotherapy for cancer. It qualifies as an unmixed immunological product under HTS 3002.13.00, not in retail forms, matching chapter note for interleukins regulating immunological processes.
Unmixed Tumor Necrosis Factor Alpha (TNF-α)
TNF-α is a cytokine involved in systemic inflammation and immune regulation, supplied in bulk for research and therapeutic development. HTS 3002.13.00 applies to this unmixed immunological product per chapter definitions for TNFs.
Bulk Rituximab Monoclonal Antibody
Rituximab targets CD20 on B-cells for lymphoma and autoimmune treatment, a biotech-produced antibody. As an unmixed product not for retail, it fits HTS 3002.13.00 immunological products definition.
Recombinant Erythropoietin (EPO)
EPO is a glycoprotein hormone stimulating red blood cell production, with immunological regulatory roles. Bulk unmixed form classifies under HTS 3002.13.00 as per immunological product notes.
Unmixed Adalimumab Biosimilar
Adalimumab biosimilar is a TNF inhibitor monoclonal antibody for rheumatoid arthritis. Supplied unmixed in bulk, it meets HTS 3002.13.00 for immunological products.
Bulk Granulocyte Colony Stimulating Factor (G-CSF)
G-CSF promotes neutrophil production, a hematopoietin per chapter notes. HTS 3002.13.00 covers this unmixed bulk immunological product.
Unmixed Trastuzumab Emtansine Conjugate
Antibody-drug conjugate targeting HER2 in breast cancer, qualifies as immunological per notes. Bulk unmixed under HTS 3002.13.00.
Recombinant Human Growth Factor (HGF)
HGF promotes cell growth and motility with immunological roles. Unmixed bulk for HTS 3002.13.00.
Bulk Infliximab
Chimeric monoclonal antibody against TNF for autoimmune diseases. HTS 3002.13.00 unmixed.
Unmixed Cetuximab
EGFR-targeting MAB for cancer. Bulk immunological product HTS 3002.13.00.
Pegfilgrastim Bulk
Pegylated G-CSF for neutropenia. Unmixed under 3002.13.00.
Unmixed Omalizumab
Anti-IgE MAB for asthma. HTS 3002.13.00 bulk.
Bulk Filgrastim
Recombinant G-CSF analog. Unmixed immunological HTS 3002.13.00.